The SENATOR project: developing and trialling a novel software engine to optimize medications and nonpharmacological therapy in older people with multimorbidity and polypharmacy

Roy L. Soiza; Selvarani Subbarayan; Cherubini  Antonio; Alfonso J.  Cruz-Jentoft; Mirko  Petrovic; Adalsteinn  Gudmundsson; Denis  O’Mahony

doi:10.1177/2042098616675851

The SENATOR project: developing and trialling a novel software engine to optimize medications and nonpharmacological therapy in older people with multimorbidity and polypharmacy

Roy L. Soiza, Selvarani Subbarayan, Cherubini Antonio, Alfonso J. Cruz-Jentoft, Mirko Petrovic, Adalsteinn Gudmundsson, Denis O’Mahony

Research output: Contribution to journal › Editorial › peer-review

35 Citations (Scopus)

6 Downloads (Pure)

Original language	English
Pages (from-to)	81-85
Number of pages	5
Journal	Therapeutic Advances in Drug Safety
Volume	8
Issue number	3
Early online date	2 Nov 2016
DOIs	https://doi.org/10.1177/2042098616675851
Publication status	Published - 1 Mar 2017

Access to Document

10.1177/2042098616675851Licence: Unspecified

Accepted Manuscript
This is the author's manuscript as accepted for publication in Therapeutic Advances in Drug Safety. Final published version available at: http://journals.sagepub.com/doi/10.1177/2042098616675851 https://us.sagepub.com/en-us/nam/journal-author-archiving-policies-and-re-use
Accepted author manuscript, 130 KBLicence: Unspecified

Cite this

Soiza, R. L., Subbarayan, S., Antonio, C., Cruz-Jentoft, A. J., Petrovic, M., Gudmundsson, A., & O’Mahony, D. (2017). The SENATOR project: developing and trialling a novel software engine to optimize medications and nonpharmacological therapy in older people with multimorbidity and polypharmacy. Therapeutic Advances in Drug Safety, 8(3), 81-85. https://doi.org/10.1177/2042098616675851

The SENATOR project : developing and trialling a novel software engine to optimize medications and nonpharmacological therapy in older people with multimorbidity and polypharmacy. / Soiza, Roy L.; Subbarayan, Selvarani; Antonio, Cherubini et al.

In: Therapeutic Advances in Drug Safety, Vol. 8, No. 3, 01.03.2017, p. 81-85.

Research output: Contribution to journal › Editorial › peer-review

Soiza, RL , Subbarayan, S, Antonio, C, Cruz-Jentoft, AJ, Petrovic, M, Gudmundsson, A & O’Mahony, D 2017, 'The SENATOR project: developing and trialling a novel software engine to optimize medications and nonpharmacological therapy in older people with multimorbidity and polypharmacy', Therapeutic Advances in Drug Safety, vol. 8, no. 3, pp. 81-85. https://doi.org/10.1177/2042098616675851

Soiza RL , Subbarayan S, Antonio C, Cruz-Jentoft AJ, Petrovic M, Gudmundsson A et al. The SENATOR project: developing and trialling a novel software engine to optimize medications and nonpharmacological therapy in older people with multimorbidity and polypharmacy. Therapeutic Advances in Drug Safety. 2017 Mar 1;8(3):81-85. Epub 2016 Nov 2. doi: 10.1177/2042098616675851

@article{4d8f40fe7dd240e9a3f533a140ee1881,

title = "The SENATOR project: developing and trialling a novel software engine to optimize medications and nonpharmacological therapy in older people with multimorbidity and polypharmacy",

author = "Soiza, {Roy L.} and Selvarani Subbarayan and Cherubini Antonio and Cruz-Jentoft, {Alfonso J.} and Mirko Petrovic and Adalsteinn Gudmundsson and Denis O{\textquoteright}Mahony",

note = "The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The work leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 305930.",

year = "2017",

month = mar,

day = "1",

doi = "10.1177/2042098616675851",

language = "English",

volume = "8",

pages = "81--85",

journal = "Therapeutic Advances in Drug Safety",

issn = "2042-0986",

publisher = "SAGE Publications Ltd",

number = "3",

}

TY - JOUR

T1 - The SENATOR project

T2 - developing and trialling a novel software engine to optimize medications and nonpharmacological therapy in older people with multimorbidity and polypharmacy

AU - Soiza, Roy L.

AU - Subbarayan, Selvarani

AU - Antonio, Cherubini

AU - Cruz-Jentoft, Alfonso J.

AU - Petrovic, Mirko

AU - Gudmundsson, Adalsteinn

AU - O’Mahony, Denis

N1 - The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The work leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 305930.

PY - 2017/3/1

Y1 - 2017/3/1

U2 - 10.1177/2042098616675851

DO - 10.1177/2042098616675851

M3 - Editorial

VL - 8

SP - 81

EP - 85

JO - Therapeutic Advances in Drug Safety

JF - Therapeutic Advances in Drug Safety

SN - 2042-0986

IS - 3

ER -